Sequential disseminated aspergillosis and pulmonary tuberculosis in a patient treated by idelalisib for chronic lymphocytic leukemia.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Médecine et maladies infectieuses

• Publication date

  2017-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.medmal.2016.10.001PMID 27818019
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• RP105 Engages Phosphatidylinositol 3-Kinase p110δ To Facilitate the Trafficking and Secretion of Cytokines in Macrophages during Mycobacterial Infection

  2015cited by this paper
• Idelalisib and rituximab in relapsed chronic lymphocytic leukemia.

  2014cited by this paper
• Alemtuzumab for patients with chronic lymphocytic leukaemia.

  2012cited by this paper
• Aspergillus fumigatus osteomyelitis in a patient receiving alemtuzumab for B‐cell chronic lymphocytic leukaemia

  2011cited by this paper
• Epidemiological trends in invasive aspergillosis in France: the SAIF network (2005-2007).

  2011cited by this paper
• Infectious complications of chronic lymphocytic leukaemia: pathogenesis, spectrum of infection, preventive approaches.

  2010cited by this paper
• Aspergillus tracheobronchitis following a fungal tongue nodule

  2008cited by this paper
• Successful treatment of tongue aspergillosis caused by Aspergillus flavus with liposomal amphotericin B in a child with acute lymphoblastic leukemia.

  2006cited by this paper
• Primary aspergillosis affecting the tongue of a leukemic patient.

  2003cited by this paper
• Invasive Aspergillus stomatitis in patients with acute leukemia: report of 12 cases.

  2001cited by this paper
• Prolonged granulocytopenia: the major risk factor for invasive pulmonary aspergillosis in patients with acute leukemia.

  1984cited by this paper

• New anticancer therapeutics impact fungal pathobiology, infection dynamics, and outcome

  2023cites this paper
• A review of prophylactic regimens to prevent invasive fungal infections in hematology patients undergoing chemotherapy or stem cell transplantation

  2023cites this paper
• Novel Therapy Approaches to Follicular Lymphoma

  2021cites this paper
• Invasive Fungal Infections and Targeted Therapies in Hematological Malignancies

  2021cites this paper
• Sunitinib Use for Metastatic Renal Cell Carcinoma Associated with Necrotizing Cavitary Pulmonary Aspergillosis with Aspergillus flavus: Case Report and Review of Literature

  2019cites this paper
• Infection control in patients treated for chronic lymphocytic leukemia with ibrutinib or idelalisib: recommendations from Italian society of hematology.

  2019cites this paper
• Invasive fungal infections in the immunocompromised host: Mechanistic insights in an era of changing immunotherapeutics.

  2019cites this paper
• New hematologic populations at risk of invasive aspergillosis: focus on new targeted, biological, and cellular therapies

  2019cites this paper
• Primary prophylaxis of invasive fungal infections in patients with haematological malignancies: 2017 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO)

  2017cites this paper